A pipeline powered by

A pipeline powered bypassion

circle

pipeline

  • Pre-Clinical
    Phase 1
    Phase 2
    Phase 3
  • CARDIAC MUSCLE
  • Omecamtiv Mecarbil (Heart Failure)
    AMGEN COLLABORATION
  • AMG 594 (Heart Failure, other)
    AMGEN COLLABORATION
  • CK-274 (HCM)
    WHOLLY OWNED
  • SKELETAL MUSCLE
  • Reldesemtiv (SMA)
    ASTELLAS COLLABORATION
  • Reldesemtiv (ALS)
    ASTELLAS COLLABORATION
  • CK-601
    ASTELLAS COLLABORATION
  • Research
  • Additional Skeletal Muscle Activators
    ASTELLAS COLLABORATION
  • Other Muscle Biology Directed Research
type
indication
phase
CARDIAC MUSCLE
Omecamtiv Mecarbil (Heart Failure) AMG 594 (Heart Failure, other) CK-274 (HCM)
3 1 1
SKELETAL MUSCLE
Reldesemtiv (SMA) Reldesemtiv (ALS) CK-601
2 2 Pre-Clinical
Research
Additional Skeletal Muscle Activators Other Muscle Biology Directed Research
Pre-Clinical Pre-Clinical
Image Description

Reldesemtiv

With Astellas, Cytokinetics is developing reldesemtiv, a fast skeletal muscle troponin activator (FSTA).

Image Description

PUBLICATIONS

We’re proud to be a leader in muscle biology research. Read more about our work to develop potential therapies for people with diseases that rob them of key muscle functions.